Immunomodulatory peptides with high binding affinity for class II MHC molecules for the prevention of graft-versus-host disease.

Published

Journal Article (Review)

Graft-versus-host disease (GVHD) represents the major barrier to successful allogeneic bone marrow transplantation. Positive and negative selection studies have unequivocally demonstrated that donor T cells are responsible for the induction phase of GVHD. Inhibition of the early steps of T cell antigen recognition leading to graft-versus-host disease has become an area of intense investigation. Peptides with high binding affinity for class II MHC molecules have been shown to compete for the single class II binding site and to inhibit T cell proliferative responses in vitro. Recent work has extended this approach to the prevention of murine GVHD in vivo.

Full Text

Duke Authors

Cited Authors

  • Schlegel, PG; Chao, NJ

Published Date

  • September 1996

Published In

Volume / Issue

  • 23 / 1-2

Start / End Page

  • 11 - 16

PubMed ID

  • 9021680

Pubmed Central ID

  • 9021680

International Standard Serial Number (ISSN)

  • 1042-8194

Digital Object Identifier (DOI)

  • 10.3109/10428199609054796

Language

  • eng

Conference Location

  • United States